These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9846807)

  • 1. Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in mice.
    Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
    Heart Vessels; 1997; 12(5):221-8. PubMed ID: 9846807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.
    Kishimoto C; Kuroki Y; Hiraoka Y; Ochiai H; Kurokawa M; Sasayama S
    Circulation; 1994 Jun; 89(6):2836-42. PubMed ID: 8205699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody therapy for prevention of acute coxsackievirus B3 myocarditis in mice.
    Kishimoto C; Abelmann WH
    Circulation; 1989 Jun; 79(6):1300-8. PubMed ID: 2541943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of effects of cyclosporine on myocardial lymphocyte subsets in Coxsackievirus B3 myocarditis in the aviremic stage.
    Kishimoto C; Abelmann WH
    Circ Res; 1989 Oct; 65(4):934-45. PubMed ID: 2551533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
    Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
    Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MIP-2 in coxsackievirus B3 myocarditis.
    Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H
    J Mol Cell Cardiol; 2000 Apr; 32(4):631-8. PubMed ID: 10756119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis.
    Kishimoto C; Kurokawa M; Ochiai H
    J Mol Cell Cardiol; 2002 Sep; 34(9):1227-38. PubMed ID: 12392896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis.
    Kishimoto C; Kuroki Y; Kurokawa M; Ohiai H
    Basic Res Cardiol; 1997 Dec; 92(6):402-9. PubMed ID: 9464864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Yagita H; Okumura K; Azuma M; Yazaki Y
    J Pathol; 1999 May; 188(1):107-12. PubMed ID: 10398149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
    Takada H; Kishimoto C; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
    Heart Vessels; 1993; 8(2):59-66. PubMed ID: 8390975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide differences of coxsackievirus B3 and chronic myocarditis.
    Kishimoto C; Takamatsu N; Ochiai H; Kuribayashi K
    Heart Vessels; 2015 Jan; 30(1):126-35. PubMed ID: 24493328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects.
    Takada H; Kishimoto C; Hiraoka Y
    Circulation; 1995 Sep; 92(6):1604-11. PubMed ID: 7664447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis.
    Kishimoto C; Thorp KA; Abelmann WH
    Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication.
    Fairweather D; Yusung S; Frisancho S; Barrett M; Gatewood S; Steele R; Rose NR
    J Immunol; 2003 May; 170(9):4731-7. PubMed ID: 12707353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
    Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
    J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on murine acute myocarditis caused by coxsackievirus B3.
    Seko Y; Takahashi N; Azuma M; Yagita H; Okumura K; Yazaki Y
    Circ Res; 1998 Mar; 82(5):613-8. PubMed ID: 9529166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus b3.
    Seko Y; Takahashi N; Yagita H; Okumura K; Yazaki Y
    J Pathol; 1997 Sep; 183(1):105-8. PubMed ID: 9370955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood.
    Kishimoto C; Misaki T; Crumpacker CS; Abelmann WH
    Circulation; 1988 Mar; 77(3):645-53. PubMed ID: 2830046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular cell adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.
    Seko Y; Yagita H; Okumura K; Yazaki Y
    J Pathol; 1996 Dec; 180(4):450-4. PubMed ID: 9014868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
    Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.